DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 5.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 53.7. According to RSI analysis, drreddy is technically strong. 9.0 DRREDDY RSI Chart
MACD (?) MACD: 31.1 and Signal Line: 37.1. According to MACD analysis, drreddy is marginally weak. 3.0 DRREDDY MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, drreddy is facing resistance at 2.38e+03 and support level is at 2219.934. 2.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is facing resistance from it's 200-day exponential moving average at 2572.035 and support level is at 2.36e+03. 7.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.457. 5.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 2287.7708 and 2213.95. Resistance level is 2526.75. 6.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 59.7 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 12.9 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 2385.0
High Price 2387.0
Low Price 2362.05
Close Price 2373.05
Absolute Change -12.35
Percentage Change -0.518%
Weekly Change -0.286%
Monthly Change 2.52%
Yearly Change -21.7%
52-week high 3399.9
52-week low 1901.15
Corporate Actions
ExDate Purpose
July 17, 2017 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.493
Confidence in Beta1.18%
Market Capital Rs. 40479.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 30
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:1.32e+04 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.3859 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 October 2017: PCR_OI:0.353 PCR:0.311 NA DRREDDY PCR Chart
Option Pain (?) 19 October 2017: Max Pain:2400.0 NA DRREDDY Option Pain Chart
Premium (?) 19 October 2017 Premium: 3.0 Futures OI:3326000.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 19 October 2017: Price:2373.05 Put with maximum OI:2300.0 Call with maximum OI:2500.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 26, 2017 2376.05 3326000.0 1080.0 1149.0 2373.05
November 30, 2017 2391.25 546200.0 274.0 377.0 2373.05

Announcements

October 17, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 16, 2017, titled "Dr. Reddy's to release Q2 FY18 results on October 31, 2017 Earnings call slated for October 31, 6.30 PM IST / 9.00 AM EDT".
October 12, 2017 Dr.Allotment of Securities. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 7987 securities pursuant to ESOP/ESPS at its meeting held on October 12, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 06, 2017 October 31, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017.
July 05, 2017 July 27, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2336 Rs. 2349 Rs. 2361 Rs. 2374 Rs. 2386 Rs. 2399 Rs. 2411